These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1030 related items for PubMed ID: 32600274

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Advances in the treatment of varicella-zoster virus infections.
    Andrei G, Snoeck R.
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nationwide distribution of varicella-zoster virus clades in China.
    Xu S, Chen M, Zheng H, Wang H, Chen M, Zhou J, Shuang W, Yu P, Ma C, He J, Feng D, Zhen Z, Yan Z, Naiying M, Cui A, Wu Q, Qi M, Li C, Xu X, Xu W.
    BMC Infect Dis; 2016 Oct 07; 16(1):542. PubMed ID: 27717328
    [Abstract] [Full Text] [Related]

  • 5. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J, Whitley R.
    Herpes; 2007 Sep 07; 14 Suppl 2():25-9. PubMed ID: 17939892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genotypes of varicella-zoster virus wild-type strains in Germany.
    Sauerbrei A, Zell R, Philipps A, Wutzler P.
    J Med Virol; 2008 Jun 07; 80(6):1123-30. PubMed ID: 18428135
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monitoring prevalence of varicella-zoster virus clades in Germany.
    Sauerbrei A, Stefanski J, Philipps A, Krumbholz A, Zell R, Wutzler P.
    Med Microbiol Immunol; 2011 May 07; 200(2):99-107. PubMed ID: 21072536
    [Abstract] [Full Text] [Related]

  • 11. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M, Breuer J.
    Expert Rev Mol Med; 2005 Aug 10; 7(15):1-24. PubMed ID: 16098235
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A co-infection of varicella-zoster virus and Pneumocystis jirovecii in a non-HIV immunocompromised patient: a case report.
    Muramatsu H, Kuriyama A, Anzai Y, Ikegami T.
    BMC Infect Dis; 2019 Dec 30; 19(1):1092. PubMed ID: 31888503
    [Abstract] [Full Text] [Related]

  • 14. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R, Aeschlimann F, Baer W, Berthet G, Cannizzaro E, Hofer M, Kaiser D, Schroeder S, Heininger U, Woerner A.
    Pediatr Rheumatol Online J; 2016 Jun 02; 14(1):34. PubMed ID: 27256096
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A, Eichhorn U, Gawellek S, Egerer R, Schacke M, Wutzler P.
    J Med Virol; 2003 Oct 02; 71(2):313-9. PubMed ID: 12938208
    [Abstract] [Full Text] [Related]

  • 18. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.
    Lopez AS, Burnett-Hartman A, Nambiar R, Ritz L, Owens P, Loparev VN, Guris D, Schmid DS.
    J Infect Dis; 2008 Mar 01; 197(5):646-53. PubMed ID: 18260757
    [Abstract] [Full Text] [Related]

  • 19. Emerging drugs for varicella-zoster virus infections.
    Andrei G, Snoeck R.
    Expert Opin Emerg Drugs; 2011 Sep 01; 16(3):507-35. PubMed ID: 21699441
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.